Guangdong Transtek Medical Electronics Co., Ltd (SHE:300562)
China · Delayed Price · Currency is CNY 14.30
-0.16 (-1.11%)
Apr 30, 2026, 2:35 PM CST
SHE:300562 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 990.56 | 980.13 | 978.02 | 878.91 | 1,060 | 1,816 |
Other Revenue | 6.08 | 6.08 | 5.96 | 5.35 | 4.97 | 4.82 |
| 996.64 | 986.21 | 983.98 | 884.26 | 1,065 | 1,821 | |
Revenue Growth (YoY) | -1.19% | 0.23% | 11.28% | -16.98% | -41.51% | 36.23% |
Cost of Revenue | 646.06 | 640.63 | 645.88 | 606.35 | 844.21 | 1,486 |
Gross Profit | 350.58 | 345.58 | 338.1 | 277.9 | 220.88 | 335.31 |
Selling, General & Admin | 138.16 | 146.66 | 182.25 | 144.41 | 133.42 | 172.94 |
Research & Development | 95.45 | 95.1 | 96.81 | 108.32 | 136.93 | 149.15 |
Other Operating Expenses | 5.72 | 5.82 | 6.65 | 7.11 | 10.05 | 5.77 |
Operating Expenses | 240.04 | 250.05 | 286.7 | 263.69 | 285.62 | 335.22 |
Operating Income | 110.53 | 95.53 | 51.39 | 14.22 | -64.74 | 0.09 |
Interest Expense | -1.57 | -2.36 | -5.35 | -4.28 | -2.42 | -2.57 |
Interest & Investment Income | 10.97 | 11.42 | 7.65 | 9.95 | 7.07 | 11.41 |
Currency Exchange Gain (Loss) | -3.87 | -3.87 | 17.23 | 7.09 | 29.91 | -9.63 |
Other Non Operating Income (Expenses) | -8.7 | -1.67 | 0.35 | 0.02 | -0.63 | -1.31 |
EBT Excluding Unusual Items | 107.36 | 99.05 | 71.28 | 27.01 | -30.81 | -2.01 |
Impairment of Goodwill | -9.05 | -9.05 | -8.55 | - | -3.44 | -4.78 |
Gain (Loss) on Sale of Investments | 0.94 | 0.43 | -0.14 | 0.79 | -6.31 | 0.22 |
Gain (Loss) on Sale of Assets | -0.02 | -0.03 | 0.09 | -0.47 | 0.38 | -0.05 |
Asset Writedown | -6.5 | -6.5 | -4.29 | -0.86 | -12.77 | -3.34 |
Legal Settlements | -1.55 | -1.55 | - | - | - | - |
Other Unusual Items | 1.99 | 1.99 | 1.64 | 6.64 | 8.39 | 6.76 |
Pretax Income | 93.16 | 84.35 | 60.04 | 33.11 | -44.57 | -3.21 |
Income Tax Expense | 3.79 | 4.08 | 1.88 | 1.91 | -6.37 | -2.93 |
Earnings From Continuing Operations | 89.37 | 80.27 | 58.16 | 31.2 | -38.2 | -0.28 |
Minority Interest in Earnings | 1.76 | 1.73 | 3.21 | 3.17 | 5.84 | 9.14 |
Net Income | 91.13 | 82 | 61.36 | 34.37 | -32.36 | 8.87 |
Net Income to Common | 91.13 | 82 | 61.36 | 34.37 | -32.36 | 8.87 |
Net Income Growth | 29.01% | 33.63% | 78.55% | - | - | -87.36% |
Shares Outstanding (Basic) | 220 | 218 | 217 | 215 | 216 | 222 |
Shares Outstanding (Diluted) | 220 | 218 | 217 | 215 | 216 | 222 |
Shares Change (YoY) | 3.82% | 0.36% | 0.87% | -0.24% | -2.70% | 16.93% |
EPS (Basic) | 0.41 | 0.38 | 0.28 | 0.16 | -0.15 | 0.04 |
EPS (Diluted) | 0.41 | 0.38 | 0.28 | 0.16 | -0.15 | 0.04 |
EPS Growth | 24.26% | 33.15% | 77.02% | - | - | -89.19% |
Free Cash Flow | 148.13 | 138.37 | 90.87 | 61.25 | 63.61 | -68.66 |
Free Cash Flow Per Share | 0.67 | 0.64 | 0.42 | 0.28 | 0.29 | -0.31 |
Dividend Per Share | 0.260 | 0.260 | 0.280 | 0.150 | 0.010 | 0.010 |
Dividend Growth | -7.14% | -7.14% | 86.67% | 1400.00% | - | -95.00% |
Gross Margin | 35.18% | 35.04% | 34.36% | 31.43% | 20.74% | 18.41% |
Operating Margin | 11.09% | 9.69% | 5.22% | 1.61% | -6.08% | 0.01% |
Profit Margin | 9.14% | 8.31% | 6.24% | 3.89% | -3.04% | 0.49% |
Free Cash Flow Margin | 14.86% | 14.03% | 9.23% | 6.93% | 5.97% | -3.77% |
EBITDA | 128.82 | 114.59 | 73.51 | 38.09 | -40.77 | 18.35 |
EBITDA Margin | 12.93% | 11.62% | 7.47% | 4.31% | -3.83% | 1.01% |
D&A For EBITDA | 18.29 | 19.05 | 22.11 | 23.87 | 23.97 | 18.26 |
EBIT | 110.53 | 95.53 | 51.39 | 14.22 | -64.74 | 0.09 |
EBIT Margin | 11.09% | 9.69% | 5.22% | 1.61% | -6.08% | 0.01% |
Effective Tax Rate | 4.06% | 4.83% | 3.14% | 5.78% | - | - |
Revenue as Reported | 996.64 | 986.21 | 983.98 | 884.26 | 1,065 | 1,821 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.